Published on in Vol 11, No 2 (2022): Jul-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39778, first published .
Ranolazine Versus Allopurinol for Eligible Symptomatic Patients With a History of Angioplasty: Comparative Efficacy Study

Ranolazine Versus Allopurinol for Eligible Symptomatic Patients With a History of Angioplasty: Comparative Efficacy Study

Ranolazine Versus Allopurinol for Eligible Symptomatic Patients With a History of Angioplasty: Comparative Efficacy Study

Journals

  1. Cesar L, Mioto B. Allopurinol versus Trimetazidine as Antianginal: A Randomized Clinical Trial. Arquivos Brasileiros de Cardiologia 2024;121(8) View
  2. Cesar L, Mioto B. Alopurinol versus Trimetazidina como Antianginal: Um Ensaio Clínico Randomizado. Arquivos Brasileiros de Cardiologia 2024;121(8) View
  3. Ziotti S, Azevedo R, Pereira T, Rosal M, Grobe S, Mendonça C, Dourado L, Cesar L, Serrano Junior C, Gowdak L. Myocardial Perfusion and Angina Improvement Following Allopurinol Therapy in a Patient With Coronary Artery Fistula. JACC: Case Reports 2025;30(23):105010 View
  4. Cesar L, Gowdak L, Pavanello R, Ferreira J, Mioto B, Poppi N, Mendonça C, Beck A, Brito A, Abizaid A, Brandão A, Falcão A, Sposito A, Sousa A, Mansur A, Macedo A, Chaves Á, Falcão B, Markman B, Nascimento B, Jordão C, Campos C, Montenegro C, Rochitte C, Serrano C, Strunz C, Moreira D, Watanabe D, Lima E, Gaui E, Alexandre E, Rached F, Jatene F, Aguiar G, Feitosa-Filho G, Pena H, Pinto I, Castro I, Scholz J, Leal J, Mangione J, Lima J, Faria J, Soares J, Maia K, Carreira L, Matos L, Dourado L, Sousa L, Dallan L, Mastrocola L, Gowdak M, França O, Coelho O, Coelho-Filho O, Behr P, Caramori P, Lemos P, Farsky P, Santos R, Lopes R, Serra S, Grobe S, Montenegro S, Barberato S, Strabelli T, Burgos U, Nina V, Gomes W, Chalela W, Mathias W. Diretriz de Síndrome Coronariana Crônica – 2025. Arquivos Brasileiros de Cardiologia 2025;122(09) View